Mirae Asset Global Investments’s ACELYRIN SLRN Stock Holding History

Mirae Asset Global Investments’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,370	Closed	-$8.76K	–	1639
2025 Q1	$8.76K	Buy	3,370 +27	+0.8%	+$64	﹤0.01%	1482
2024 Q4	$10.9K	Sell	3,343 -267	-7%	-$1.29K	﹤0.01%	1507
2024 Q3	$17.8K	Buy	3,610 +654	+22%	+$3.38K	﹤0.01%	1449
2024 Q2	$11.7K	Buy	+2,956	New	+$13.9K	﹤0.01%	1448
2024 Q1	–	Sell	-17,038	Closed	-$127K	–	2633
2023 Q4	$127K	Sell	17,038 -3,158	-16%	-$27K	﹤0.01%	2417
2023 Q3	$205K	Buy	+20,196	New	+$429K	﹤0.01%	2284

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global Investments's SLRN Position: Q2 2025 in Review

Mirae Asset Global Investments sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 3,370 shares — an estimated $8.76K sold.

Mirae Asset Global Investments first reported a position in SLRN in Q3 2023 and held it in 6 quarters. The position peaked at $205K in Q3 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Mirae Asset Global Investments reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Mirae Asset Global Investments sold 3,370 ACELYRIN shares in Q2 2025, an estimated $8.76K.
Mirae Asset Global Investments first reported a position in ACELYRIN in Q3 2023 and held it in 6 quarters.
Mirae Asset Global Investments's ACELYRIN position peaked at $205K in Q3 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.